发明名称 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products
摘要 The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins, and which additionally reverse pre-formed crosslinks in the advanced glycosylation endproducts by cleaving alpha-dicarbonyl-based protein crosslinks present in the advanced glycosylation endproducts. Certain agents useful are thiazolium salts. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated. A novel immunoassay for detection of the reversal of the nonenzymatic crosslinking is also disclosed.
申请公布号 EP1327887(A2) 申请公布日期 2003.07.16
申请号 EP20030075955 申请日期 1996.01.18
申请人 SYNVISTA THERAPEUTICS, INC.;THE PICOWER INSTITUTE FOR MEDICAL RESEARCH 发明人 CERAMI, ANTHONY;ULRICH, PETER C.;WAGLE, DILIP R.;HWANG, SAN-BAO;VASAN, SARA;EGAN, JOHN J.
分类号 G01N33/53;A61K8/49;A61K31/425;A61K31/426;A61K31/428;A61P3/08;A61P13/02;A61P15/00;A61P27/02;A61Q11/00;A61Q19/00;A61Q19/08;C07D277/20;C07D277/22;C07D277/24;C07D277/38;C07D277/40;C07D277/64;G01N33/15;(IPC1-7):G01N33/68;G01N33/58 主分类号 G01N33/53
代理机构 代理人
主权项
地址